ClinicalTrials.Veeva

Menu

New Therapeutic System of Ruptured Intracranial Aneurysms Based on Big Data From Chinese Population (NATIONAL-2)

N

Naval Military Medical University

Status

Unknown

Conditions

Subarachnoid Hemorrhage, Aneurysmal

Study type

Observational

Funder types

Other

Identifiers

NCT03153748
CHEC2017-074

Details and patient eligibility

About

This study aims at clarifying the current situation of Emergency treatment of aneurysmal subarachnoid hemorrhage (SAH) in China, and analyzing the safety and efficacy of the treatment strategy between interventional treatment and open surgery, so as to improve the diagnosis and treatment of aneurysmal SAH.

Enrollment

10,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients presented with subarachnoid hemorrhage on CT or lumbar puncture.
  • the intracranial hemorrhage was caused by rupture of aneurysm and was confirmed on CTA、MRA or DSA.
  • patients willing to participate in this clinical trial and attach to regular follow up.

Exclusion criteria

  • intracranial aneurysm correlating to AVM.
  • dissection, false, traumatic and infectious aneurysms.
  • the rupture of the aneurysm can not be confirmed on CTA、MRA or DSA.
  • patients unwilling to participate in this clinical trial and attach to regular follow up.

Trial contacts and locations

1

Loading...

Central trial contact

Pengfei Yang, MD; Hongjian Zhang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems